92 related articles for article (PubMed ID: 17015257)
21. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
22. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
23. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
24. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
25. Protection by tropolones against H2O2-induced DNA damage and apoptosis in cultured Jurkat cells.
Doulias PT; Nousis L; Zhu BZ; Frei B; Galaris D
Free Radic Res; 2005 Feb; 39(2):125-35. PubMed ID: 15763960
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.
Boffa LC; Cutrona G; Cilli M; Matis S; Damonte G; Mariani MR; Millo E; Moroni M; Roncella S; Fedeli F; Ferrarini M
Cancer Gene Ther; 2007 Feb; 14(2):220-6. PubMed ID: 17053816
[TBL] [Abstract][Full Text] [Related]
28. Hypothermia injury/cold-induced apoptosis--evidence of an increase in chelatable iron causing oxidative injury in spite of low O2-/H2O2 formation.
Rauen U; Petrat F; Li T; De Groot H
FASEB J; 2000 Oct; 14(13):1953-64. PubMed ID: 11023979
[TBL] [Abstract][Full Text] [Related]
29. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
[TBL] [Abstract][Full Text] [Related]
30. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of hydrogen peroxide-induced apoptosis of the human osteosarcoma cell line HS-Os-1.
Ogawa Y; Takahashi T; Kobayashi T; Kariya S; Nishioka A; Mizobuchi H; Noguchi M; Hamasato S; Tani T; Seguchi H; Yoshida S; Sonobe H
Int J Mol Med; 2003 Oct; 12(4):459-63. PubMed ID: 12964019
[TBL] [Abstract][Full Text] [Related]
32. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
33. Effects of iron salts and haemosiderin from a thalassaemia patient on oxygen radical damage as measured in the comet assay.
Anderson D; Yardley-Jones A; Hambly RJ; Vives-Bauza C; Smykatz-Kloss V; Chua-Anusorn W; Webb J
Teratog Carcinog Mutagen; 2000; 20(1):11-26. PubMed ID: 10607374
[TBL] [Abstract][Full Text] [Related]
34. Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells.
Simões Magluta EP; Vasconcelos FC; Maia RC; Klumb CE
Cancer Invest; 2009 Oct; 27(8):830-5. PubMed ID: 19557576
[TBL] [Abstract][Full Text] [Related]
35. PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease.
Matis S; Mariani MR; Cutrona G; Cilli M; Piccardi F; Daga A; Damonte G; Millo E; Moroni M; Roncella S; Fedeli F; Boffa LC; Ferrarini M
Cancer Gene Ther; 2009 Oct; 16(10):786-93. PubMed ID: 19363465
[TBL] [Abstract][Full Text] [Related]
36. Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity -- role for iron-dependent oxidative stress.
Thomas SR; Schulz E; Keaney JF
Free Radic Biol Med; 2006 Aug; 41(4):681-8. PubMed ID: 16864001
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis in Burkitt lymphoma cells is driven by c-myc.
Milner AE; Grand RJ; Waters CM; Gregory CD
Oncogene; 1993 Dec; 8(12):3385-91. PubMed ID: 8247541
[TBL] [Abstract][Full Text] [Related]
38. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Vettraino M; Manerba M; Govoni M; Di Stefano G
Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
[TBL] [Abstract][Full Text] [Related]
39. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells.
Yalowich JC; Gorbunov NV; Kozlov AV; Allan W; Kagan VE
Biochemistry; 1999 Aug; 38(33):10691-8. PubMed ID: 10451363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
